Vericel Corp. (VCEL)
33.94
-1.43
(-4.04%)
USD |
NASDAQ |
Apr 16, 15:45
Vericel Research and Development Expense (Quarterly) : 7.253M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 5.006M |
| Marker Therapeutics, Inc. | 2.141M |
| Moderna, Inc. | 708.00M |
| Krystal Biotech, Inc. | 13.23M |
| Tenaya Therapeutics, Inc. | 14.80M |